Meet Janeta
Janeta Popovici-Muller, Ph.D.
Janeta is a successful biotech and pharma executive with 25 years of experience across diverse therapeutic areas and drug modalities. With expertise in small molecule development from concept through early clinical stages, Janeta has a proven track record of advancing clinical candidates that led to three FDA-approved therapeutics (Tibsovo®, Voranigo®, Pyrukynd®). As a driven biotech innovator, Janeta has extensive experience shaping portfolio and corporate strategy, managing budgets, and establishing strategic CRO partnerships to enhance internal R&D capabilities. Founder of Ivora Consulting, Janeta is dedicated to enabling biotech companies, venture firms and academic institutions to successfully discover and develop novel small molecule therapeutics.